These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36973751)
1. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma. Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751 [TBL] [Abstract][Full Text] [Related]
2. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes. Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma. Wu M; Yuan H; Li X; Liao Q; Liu Z Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141 [No Abstract] [Full Text] [Related]
4. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer. Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328 [TBL] [Abstract][Full Text] [Related]
5. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma. Wang L; Yao B; Yang J; Tian Z; He J BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684 [TBL] [Abstract][Full Text] [Related]
6. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma. Li S; Ran MY; Qiao H Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215 [TBL] [Abstract][Full Text] [Related]
7. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer. Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452 [TBL] [Abstract][Full Text] [Related]
8. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram. Chen F; Li Z; Deng C; Yan H J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma. Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816 [TBL] [Abstract][Full Text] [Related]
10. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer. Ding Y; Li P; Wang W; Liu F Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma. Shi J; Wu P; Sheng L; Sun W; Zhang H Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147 [TBL] [Abstract][Full Text] [Related]
12. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer. Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112 [TBL] [Abstract][Full Text] [Related]
13. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database. Wang M; Li R; Zou X; Wei T; Gong R; Zhu J; Li Z Medicine (Baltimore); 2020 Aug; 99(35):e21996. PubMed ID: 32871952 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer. Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer. Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873 [TBL] [Abstract][Full Text] [Related]
16. Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy. Xie W; Zeng Y; Hu L; Hao J; Chen Y; Yun X; Lin Q; Li H Front Immunol; 2022; 13():991656. PubMed ID: 36211409 [TBL] [Abstract][Full Text] [Related]
18. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma. Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514 [No Abstract] [Full Text] [Related]
20. A prognostic nomogram for papillary thyroid cancer lymph node metastasis based on immune score. Lu Y; Qian K; Fei M; Guo K; Shi Y; Wang Z Front Endocrinol (Lausanne); 2022; 13():993856. PubMed ID: 36531470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]